Skip to Main Content
TRC_PL _Site
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Student Resources
    • Faculty & Preceptor Resources
    • Journal Club
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Amylin Agonist

Amylin Agonist

  • Diabetes (924)
    • Blood Glucose Meters (10)
    • Complications (205)
    • Diabetes in Pregnancy (12)
    • Diabetes Meds (89)
    • Drug-Induced Hypo/Hyperglycemia (141)
    • Monitoring (145)
    • Natural Medicines/Supplements (13)
    • Prevention (47)
    • Treatment (390)
      • Alpha-Glucosidase Inhibitors (27)
      • Amylin Agonist (20)
      • Bromocriptine (10)
      • Combination Products (23)
      • Gliptins (86)
      • Glitazones (129)
      • GLP-1 (42)
      • Incretin Enhancers/Mimetics (88)
      • Insulin (202)
      • Meglitinides (46)
      • Metformin (167)
      • SGLT2 Inhibitors (94)
      • Sulfonylureas (133)
      • Treatment of Pediatric Metabolic Syndrome (10)
  • Endocrinology (12)
  • Hyperglycemia (40)
  • Hypoglycemia (19)
  • Other (32)
  • Prediabetes (5)
  • Resources (277)
  • Thyroid Disorders (65)
16 - 20 of 20 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: CDA Clinical Practice Guidelines on Monitoring Glycemic Control August 2008
Guideline: ADA Position Statement on Standards of Medical Care in Diabetes - 2008 August 2008
Commentary: A1c: How Low Should You Go? August 2008
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) November 2006
Guideline: American Diabetes Association Position Statement on Insulin Administration (2004) September 2006
  • « Prev
  • 1
  • 2
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved